Globus Medical GMED has seen impressive momentum in the past year, with its shares soaring 62.1%. It has significantly outperformed the industry’s 7.3% rise and the S&P 500 composite’s 24.8% gain.

When Globus Medical Inc. (NYSE: GMED) reported its third-quarter results in November, investors likely had no idea what was to come. Over the next few months, the musculoskeletal-solutions company ...

Medical device company Globus Medical (NYSE:GMED) in Q1 CY2025, with sales falling 1.4% year on year to $598.1 million. On the other hand, the company’s full-year revenue guidance of $2.85 ...

Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, announced the introduction of RISE®-L, a lateral lumbar interbody fu ...

Globus Medical Inc said on Thursday it would acquire peer NuVasive Inc in an all-stock deal valued at about $3 billion to build scale in the competitive market for spinal devices.

Globus Medical, Inc. posted strong Q4 results and made another recent acquisition of a firm called Nevro, ... Management mentioned its U.S. spine business saw a 4% y/y rise in revenues, ...

One possible growth explanation, according to Mike Schields, director of group sales and emerging markets for the Globus family of brands, is that 2010 marks the anniversary of Oberammergau's ...

Globus Medical started 2025 on a solid note, but a deal for loss-making Nevro creates some discomfort among investors. Read why I'm neutral on GMED stock.

In 2025, the Globus family of brands is rolling out a FAM program like no other. With BDMs leading the way, 1,500 travel advisors will be invited to experience Globus tours and Avalon river cruises ...

When the merger closes, Globus shareholders will own about 72% of the combined company. Inside Montco medical device firm's $3.1 billion proposed merger Montco medical device developer agrees to ...